Crossmark

Costs of Cancer Care for Elderly Patients with Neuroendocrine Tumors

Crossref DOI link: https://doi.org/10.1007/s40273-018-0656-z

Published Online: 2018-04-23

Published Print: 2018-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Shen, Chan

Dasari, Arvind

Gu, Dian

Chu, Yiyi

Zhou, Shouhao

Xu, Ying

Halperin, Daniel

Fu, Shuangshuang

Yao, James C.

Shih, Ya-Chen Tina
Funding

Funding for this research was provided by:

Ipsen
License Information

Text and Data Mining valid from 2018-04-23
More Information

Article History

First Online: 23 April 2018

Compliance with Ethical Standards

:

: This work was supported in part by Ipsen. The funder sponsored the purchase of SEER-Medicare data and provided funding for analytical support.

: Chan Shen, Arvind Dasari, Dian Gu, Yiyi Chu, Shouhao Zhou, Ying Xu, Daniel Halperin, Shuangshuang Fu, and Ya-Chen Tina Shih declare they have no financial or non-financial conflicts of interest that are directly relevant to the content of this article. James C. Yao declares consulting fees or honorarium from Novartis and Ipsen.

: The data source used for this study is SEER registry data linked with Medicare claims. It is available upon request from the SEER-Medicare program.